Skip to main content
. 2021 Sep 4;20:176. doi: 10.1186/s12933-021-01368-6

Fig. 2.

Fig. 2

Comparison of survival curves for the secondary outcomes between patients on VKAs or DOACs at COVID-19 diagnosis after propensity score matching. Purple line: Prior VKA use; Green line: Prior DOAC use